Cancer Treatment Registry




Login


Anastrozole

Category: Adjunctive to Chemo & Radiation

Other Names: Arimidex

Anastrozole (INN, trade name: Arimidex) is a drug indicated in the treatment of breast cancer in post-menopausal women. It is used both in adjuvant therapy (i.e. following surgery) and in metastatic breast cancer. It has the effect of decreasing the amount of estrogens that the body makes.

Anastrozole belongs in the class of drugs known as aromatase inhibitors. It inhibits the enzyme aromatase, which is responsible for converting androgens (produced by women in the adrenal glands) to estrogens.

The ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial represents a long-term follow-up study of 9366 women with localized breast cancer who received either anastrozole, tamoxifen, or both. After more than 5 years the group that received anastrozole had significantly better clinical results than the tamoxifen group. The trial suggested that anastrozole is the preferred medical therapy for postmenopausal women with localized breast cancer that is estrogen receptor positive.

Google it: Anastrozole

Add A Comment


NEWS

Newest Member   User name: JohnD
  Location: Add Other Location     
  Washington, 98382 Age: 69

Newest Treatment MSQ Nutritional Therapy
Type: Nutritional

Most Viewed IP6
Type: Nutritional

Most Used Treatment Chemotherapy
Type: Chemotherapy




Home View-Patients View-Treatments View-Statistics View-Doctors Sitemap Sponsors Contact